SAN FRANCISCO - May 9, 2022 - (Newswire.com) Blue Note Therapeutics and Bixink Therapeutics, a bio-subsidiary of KPS, today announced that the companies have entered into an exclusive lic.
New York, New York (PRWEB) March 30, 2022 Approximately 39.5 percent of men and women will be diagnosed with cancer at some point of their lifetime. These